OPOn Behalf Of The Australian Pathogen Genomics Program Partners
On Behalf Of The Australian Pathogen Genomics Program Partners
+3
SUMMARY: Pathogen genomics, including whole-genome sequencing (WGS) and clinical metagenomics, is a transformative technology increasingly being implemented in clinical microbiology, including in hospital laboratories. Pathogen genomics can improve the control of healthcare-associated infections, provide rapid infection diagnosis, and could enable replacement of laborious microbiology tests. To date, real-world implementation of pathogen genome sequencing has primarily been limited to public health laboratories, but sequencing in the clinical microbiology setting has the potential to provide advantages, including turnaround time and ability to focus on local priorities. In this review, we consider the factors that represent barriers to, and potential enablers of, the implementation of pathogen genomics in clinical microbiology, including the availability of funding and genomics-trained staff. We outline key use cases and implementation models of pathogen genomics in clinical microbiology and suggest a broad framework for labs commencing sequencing. Finally, we consider future opportunities, including direct-from-specimen sequencing, the role of machine learning in genomics analysis, and the application of pathogen genomics to clinical decision support.
Lung involvement in patients with leptospirosis is associated with a more complicated disease course. However, the demographic and clinical associations of lung involvement are incompletely defined, and its optimal management is uncertain. This retrospective study examined consecutive patients admitted to a referral hospital in tropical Australia, with laboratory-confirmed leptospirosis between January 2015, and June 2024. Lung involvement was defined as new lung parenchymal changes on chest imaging at any point during the patients’ hospitalisation. The demographics, clinical findings and clinical course of the patients with and without lung involvement were compared. The median (interquartile range (IQR)) age of the 109 patients was 39 (24–56) years; 93/109 (85%) were male. Lung involvement was present in 62/109 (57%), 55 (89%) of whom had no documented comorbidities. Patients with lung involvement received antibiotics later in their disease course than those without lung involvement (after a median (IQR) of 5 (4–6) versus 3 (2–5) days of symptoms, p = 0.001). Lung involvement was frequently associated with multi-organ failure: patients with lung involvement were more likely to require intensive care unit admission than patients without lung involvement (41/62 (66%) versus 15/47 (32%), p < 0.001). Overall, 30/109 (28%) satisfied criteria for acute respiratory distress syndrome (ARDS) and 26/109 (24%) developed pulmonary haemorrhage. Patients with lung involvement received cautious fluid resuscitation, vasopressor support and prompt initiation of additional supportive care—including mechanical ventilation, renal replacement therapy and extracorporeal membranous oxygenation—guided by the patients’ physiological parameters and clinical trajectory. All 109 patients in the cohort were alive 90 days after discharge. Life-threatening lung involvement was identified in the majority of individuals in this cohort and occurred in young and otherwise well individuals. However, in Australia’s well-resourced health system excellent outcomes can be achieved using a standard contemporary approach to the management of a patient with undifferentiated infection while a confirmed diagnosis of leptospirosis is awaited.
TAThe Wastewater Surveillance Working Group, Communicable Diseases Genomics Network of Australia
The Wastewater Surveillance Working Group, Communicable Diseases Genomics Network of Australia
+3
Wastewater pathogen surveillance was rapidly implemented across Australia and New Zealand as a public health tool during the COVID-19 pandemic. To assess method consistency and identify opportunities for harmonization, we surveyed all Australian and New Zealand Laboratories conducting government-funded wastewater pathogen surveillance. The survey demonstrated alignment of some method choices, particularly municipal wastewater treatment plant (WWTP) sampling and the use of electromagnetic membrane filtration followed by RT-qPCR. However, key differences were observed in the wastewater sample volumes; nucleic acid purification methods; validation approaches; and sequencing, analysis, and reporting methods for SARS-CoV-2 lineages. A lack of consensus on best-practice methods was evident, highlighting the need for interlaboratory sample and data exchanges to support validation and comparability. Following the pandemic period, several jurisdictional programs were discontinued despite the mounting international evidence for the utility of wastewater-based epidemiology for a range of pathogens. Subsequently, a nationally funded program was announced in Australia, necessitating the re-establishment of laboratory capacity for some jurisdictions and expansion of target pathogens for other centers. The results of this survey are intended to inform the re-establishment and enhancement of regional capacity and to provide a foundation for best-practice knowledge sharing and approach harmonization.
Lung involvement in patients with leptospirosis is associated with a more complicated disease course. However, the demographic and clinical associations of lung involvement are incompletely defined, and its optimal management is uncertain. This retrospective study examined consecutive patients admitted to a referral hospital in tropical Australia, with laboratory-confirmed leptospirosis between January 2015, and June 2024. Lung involvement was defined as new lung parenchymal changes on chest imaging at any point during the patients’ hospitalisation. The demographics, clinical findings and clinical course of the patients with – and without – lung involvement were compared. The median (interquartile range (IQR)) age of the 109 patients was 39 (24-56) years; 93/109 (85%) were male. Lung involvement was present in 62/109 (57%), 55 (89%) of whom had no documented comorbidities. Patients with lung involvement re-ceived antibiotics later in their disease course than those without lung involvement (median (IQR): 5 (4-6) versus 3 (2-5) days of symptoms, p=0.001). Lung involvement was frequently just one component associated with multi-organ failure: patients with lung involvement were more likely to require inten-sive care unit admission than patients without lung involvement (41/62 (66%) versus 15/47 (32%), p< 0.001). Overall, 30/109 (28%) satisfied criteria for acute respiratory distress syndrome (ARDS) and 26/109 (24%) developed pulmonary haemorrhage. Patients with lung involvement received cautious fluid resuscitation, vasopressor support and prompt initiation of additional supportive care – including me-chanical ventilation, renal replacement therapy and extracorporeal membranous oxygenation – guided by the patients’ physiological parameters and clinical trajectory. All 109 patients in the cohort were alive 90 days after discharge. Life-threatening lung involvement can complicate leptospirosis in young and otherwise well individuals. However, in Australia’s well-resourced health system excellent outcomes can be achieved using a standard contemporary approach to the management of a patient with undif-ferentiated infection while a confirmed diagnosis of leptospirosis is awaited.